Clinical Research and Development in PHEs – (I): Therapeutics

17th June 2020
16:00 - 17:00

Watch the webinar in full

Recording

Introduction

This webinar examined the way clinical research and development has addressed the need for therapeutics, in response to the COVID-19 pandemic. It addressed the following questions:

  1. How has clinical research and pharmaceutical medicine addressed the need for repurposing therapeutics in response to COVID-19? Have we been successful? Are new approaches needed for repurposing pharmaceuticals in the future?
  2. How has clinical research and pharmaceutical medicine approached the development of new therapeutics in response to COVID-19? Have we been successful? Are new approaches needed for repurposing pharmaceuticals in the future? Amid a PHE, are we able to respond effectively to the needs of patients? The patients affected by the disease of the pandemic (i.e., COVID-19)? The patients affected by other diseases?

Preparedness training webinar series

This webinar is part of our series on Preparedness Planning for Public Health Emergencies.

Find out more.

To find out about sponsorship opportunities for this series please email Will Strange at w.strange@fpm.org.uk 

Meet the speakers

Moderator:
Dr Penny Ward, Chair of the Education and Standards Committee, FPM; United Kingdom

Panellists:

  • Dr Susan Tansey, Boyds Consultants & Member of the Nuffield Council; United Kingdom
  • Mr Wilfred Gurupira, Research Pharmacist and HPTN International Scholar, UZ College of Health Sciences Clinical Trials Research Centre UZ CHS-CTRC; Research Head, COVID-19 Research and Advocacy Project, African Alliance; Zimbabwe
  • Dr Karol Szczukiewicz, Member of the Board, Association of Good Clinical Practice in Poland (GCPpl); Global Trial Manager, The Janssens Pharmaceutical Companies of Johnson & Johnson; Poland
  • Dr Jina Swartz, Executive Medical Director, MSD European Innovation Hub, United Kingdom

Recommended reading